` 7649 (Sugi Holdings Co Ltd) vs Nikkei 225 Comparison - Alpha Spread

S
7649
vs
N
Nikkei 225

Over the past 12 months, Sugi Holdings Co Ltd has outperformed Nikkei 225, delivering a return of +43% compared to the Nikkei 225's +29% growth.

Stocks Performance
7649 vs Nikkei 225

Loading
7649
Nikkei 225
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
7649 vs Nikkei 225

Loading
7649
Nikkei 225
Difference
www.alphaspread.com

Performance By Year
7649 vs Nikkei 225

Loading
7649
Nikkei 225
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Sugi Holdings Co Ltd vs Peers

Nikkei 225
7649
WBA
RADL3
3088
4164
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Sugi Holdings Co Ltd
Glance View

Market Cap
661.8B JPY
Industry
Retail

In the bustling realm of Japan's retail sector, Sugi Holdings Co., Ltd. has carved out a formidable presence, quietly steering the ship of healthcare-focused retailing. Established in 1976 and headquartered in Aichi Prefecture, the company operates an extensive network of pharmacies and drugstores under the Sugi Pharmacy, Japan Co., Ltd., and Japan Wellness segments. With its core focus on pharmaceuticals, cosmetics, and daily essentials, Sugi Holdings has adeptly woven itself into the fabric of everyday life for many Japanese consumers. The company strategically places its outlets in residential areas, enabling easy access and convenience, which has proven instrumental in capturing a loyal customer base. Its business model hinges on the dual approach of brick-and-mortar stores complemented by an online presence, where e-commerce facilitates a broader reach while maintaining a personal touch through storefront interactions. The engine that propels Sugi Holdings' revenue generation is its diversified product range, which spans prescription drugs, healthcare products, and an assortment of consumer goods. This diversity orchestrates a steady, reliable cash flow, largely buffered by the recurring nature of pharmaceutical sales. In addition to retail, they offer in-home medical care services, catering to an aging population—a demographic with growing healthcare needs. The company's business acumen is reflected in its adept supply chain management and strategic pricing, which enhance both operational efficiency and competitive positioning. By embracing digital tools and data analytics to better understand consumer behavior, Sugi Holdings continues to refine its offerings, ensuring sustainable growth in a dynamic retail landscape.

Intrinsic Value
3 690.25 JPY
Undervaluation 1%
Intrinsic Value
Price
S
Back to Top